Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Signifor LAR (Pasireotide) is a type of medication known as a somatostatin analog, which works by mimicking the hormone somatostatin. It attaches itself to somatostatin receptors, and by doing so, can help to control the overproduction of certain hormones. Medically, doctors prescribe Signifor LAR mainly to manage Cushing’s disease, a condition in which the pituitary gland releases too much cortisol. It is also approved for acromegaly. This long-acting formulation, designed for intramuscular injection, gradually releases Pasireotide over a period of time, aiming to maintain a steady hormonal balance.
Signifor LAR is an injectable medication that healthcare professionals administer intramuscularly, meaning it’s injected into a muscle. Patients typically receive a dose once every four weeks to manage conditions such as Cushing's disease and acromegaly. Initial dosing may vary based on the specific condition; however, for treating Cushing's disease, the starting dose is typically 10 mg, and for treating acromegaly, it is often 40 mg.
It's crucial to adhere to the dosage and administration schedule as detailed by a healthcare provider, since adjustments might be necessary based on the patient's response to therapy and any potential side effects. Patients should also be mindful of the medication’s visual appearance, avoiding use if the suspension appears discolored or contains particles.
The active ingredient in Signior LAR is Pasireotide.
There are no reported contraindications listed on the drug label.
Common side effects of the Signifor LAR injection include diarrhea, headache, stomach pain, hair loss, nasal congestion, sore throat, nausea, and fatigue. Other issues include stomach bloating, low blood sugar, high blood pressure, limb swelling, and back pain. While typically manageable, these side effects can affect daily life.
More serious concerns include high blood sugar and diabetes, with potentially severe complications like ketoacidosis, which requires urgent medical attention. Symptoms include excessive thirst, frequent urination, nausea, and confusion. Signifor LAR can also slow heart rate, particularly in those with heart conditions or those on certain medications, with symptoms such as weakness and fainting.
The medication may cause liver function abnormalities and gallstones, leading to significant abdominal pain and potential gallbladder issues. Monitoring through blood tests and ultrasound is recommended to manage these risks. Additionally, the drug can decrease pituitary hormone levels, presenting as fatigue, dizziness, and weight loss, necessitating regular hormonal level assessments.